Health · 3 views
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic…
AI Summary
Mayo Clinic researchers reported that GLP‑1 receptor agonists, drugs commonly prescribed for diabetes and weight management, were linked to a reduced risk of dialysis or kidney transplantation in adults who have both bipolar disorder and chronic kidney disease. The study, published in the Journal of Clinical Psychiatry, indicates that this popular medication class may provide an added benefit by protecting kidney health in a high‑risk population.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Long and interstate travel may be a barrier to care for certain pediatric cancer patientsContinue reading
- Unclogging carotid artery fails to improve cognition in clinical trialContinue reading
- Severe distress after trauma does not always mean lasting harm, new study findsContinue reading
- Trump orders creation of NIH division, task force on women’s healthContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow